SCHEMBL5048740

SCHEMBL5048740

CC(=C1SC(=O)NC1=O)c1ccc(OCCOc2c(-c3ccc(Cl)cc3)n(C)c3ccccc3c2=O)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.37
TSHR P16473 2/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 2/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
RXFP1 Q9HBX9 3/20 0.36
CISD1 Q9NZ45 1/20 0.35
HTR5A P47898 1/20 0.35
HSD17B10 Q99714 2/20 0.34
CYP2C19 P33261 1/20 0.34
MAPT P10636 3/20 0.34
POLB P06746 2/20 0.34
ALOX15 P16050 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TP53 P04637 1/20 0.34
PTGES O14684 1/20 0.34
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5048738 1.00 KMT2A (0.37) KMT2ATSHRMEN1ALDH1A1KDM4E
SCHEMBL14011638 0.93 ALDH1A1 (0.36) KMT2ATSHRMEN1ALDH1A1KDM4E
SCHEMBL4036673 0.93 KDM4E (0.36) KMT2AALDH1A1KDM4EHPGDHTR5A
SCHEMBL5045164 0.93 KDM4E (0.36) KMT2AALDH1A1KDM4EHPGDHTR5A
SCHEMBL4045700 0.90 PKM (0.34) KMT2AALDH1A1KDM4EHPGDRXFP1
SCHEMBL4045702 0.90 PKM (0.34) KMT2AALDH1A1KDM4EHPGDRXFP1
SCHEMBL4042288 0.90 KDM4E (0.36) KMT2AALDH1A1KDM4EHPGDCISD1
SCHEMBL4042290 0.90 KDM4E (0.36) KMT2AALDH1A1KDM4EHPGDCISD1
SCHEMBL5047027 0.88 POLB (0.34) HTR5APOLBPTGES
SCHEMBL5047026 0.88 POLB (0.34) HTR5APOLBPTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456288-B2 Heterocyclic compounds and methods of making and using thereof REDDY US THERAPEUTICS, INC. (US) 2008-11-25 US disclosed
US-20050119269-A1 Heterocyclic compounds and methods of making and using thereof DR. REDDY'S LABORATORIES LTD. (IN) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119269-A1 Heterocyclic compounds and methods of making and using thereof PYGM, MYLK, HMOX1 KMT2A 3813/4885TSHR 4558/4885MEN1 3607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.